Remdesivir for the Treatment of Covid-19 — Final Report

BACKGROUND: Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious. METHODS: We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who...

Descripción completa

Detalles Bibliográficos
Autores principales: Beigel, John H., Tomashek, Kay M., Dodd, Lori E., Mehta, Aneesh K., Zingman, Barry S., Kalil, Andre C., Hohmann, Elizabeth, Chu, Helen Y., Luetkemeyer, Annie, Kline, Susan, Lopez de Castilla, Diego, Finberg, Robert W., Dierberg, Kerry, Tapson, Victor, Hsieh, Lanny, Patterson, Thomas F., Paredes, Roger, Sweeney, Daniel A., Short, William R., Touloumi, Giota, Lye, David Chien, Ohmagari, Norio, Oh, Myoung-don, Ruiz-Palacios, Guillermo M., Benfield, Thomas, Fätkenheuer, Gerd, Kortepeter, Mark G., Atmar, Robert L., Creech, C. Buddy, Lundgren, Jens, Babiker, Abdel G., Pett, Sarah, Neaton, James D., Burgess, Timothy H., Bonnett, Tyler, Green, Michelle, Makowski, Mat, Osinusi, Anu, Nayak, Seema, Lane, H. Clifford
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262788/
https://www.ncbi.nlm.nih.gov/pubmed/32445440
http://dx.doi.org/10.1056/NEJMoa2007764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262788/
https://www.ncbi.nlm.nih.gov/pubmed/32445440
http://dx.doi.org/10.1056/NEJMoa2007764

Ejemplares similares